During this study, commercially available wearable devices connected to a smartphone collected data on the response of 2 different medications as prescribed as part of the clinical trial called RATE-AF, which was funded by the NIHR.
The study led by researchers from the cardA/c group at the University of Birmingham used artificial intelligence (AI) to help analyze over 140 million data points for heart rate in 53 participants with an average age of 76 years old over 20 weeks. The team found that even after accounting for differences in physical activity, digoxin and beta-blockers had a similar effect on heart rate, in contrast to previous studies that had only assessed the short-term impact of digoxin.
The team developed an AI network to take into account missing information to avoid an over-optimistic view of the wearable datastream. Using this approach, the team discovered that the wearables were the equivalent of standard tests that are often used in clinical trials and hospitals that require staff time and resources. The age of the participants highlights the further efficient future value of wearables regardless of age or experience with technology.
“People across the world are increasingly using wearable devices in their daily lives to help monitor their activity and health status. This study shows the potential to use this new technology to assess the response to treatment and make a positive contribution to the routine care of patients,” said Professor Dipak Kotecha from the Institute of Cardiovascular Sciences at the University of Birmingham and the lead author of the study.
“Heart conditions such as atrial fibrillation and heart failure are expected to double in prevalence over the next few decades, leading to a large burden on patients as well as substantial healthcare costs. This study is an exciting showcase for how artificial intelligence can support new ways to help treat patients better.”
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN does not agree or disagree with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement. Additionally, it is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything. These statements have not been evaluated by the Food and Drug Administration.
Content may be edited for style and length.
References/Sources/Materials provided by:
